Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing Licenses Biomics IP to Develop Bacterial ID Technology

NEW YORK, Sept. 3 - Swedish biotech company Biomics has granted countrymate Pyrosequencing an exclusive worldwide license to use its Endoribonuclease P gene, Pyrosequencing said.


The agreement, through which Pyro hopes to develop bacterial diagnostics, gives Pyro the right to sublicense the gene to collaborators. In exchange, Pyro will fund research in which Biomics will use its PSQ 96 technology to sequence, and thus validate, the RNase P gene in a variety of micro-organisms.

Click here for more information.